Home

Dobrý pocit Státní občanství Buď opatrný zucman rossi stefano caruso Slovo těhotná opar

Our Research
Our Research

Chronic Alcohol Use : Genetic Variations Provide Protection from Liver  Cancer | Université Paris Cité
Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer | Université Paris Cité

Deleting the β-catenin degradation domain in mouse hepatocytes drives  hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect

Catching up with Stefano Caruso | Ice-dance.com
Catching up with Stefano Caruso | Ice-dance.com

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes  Liver Necroptosis by Targeting FADD
Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD

JILL PILET | Institut Curie
JILL PILET | Institut Curie

The molecular road map of HCC
The molecular road map of HCC

Frontiers | The Role of Chronic Liver Diseases in the Emergence and  Recurrence of Hepatocellular Carcinoma: An Omics Perspective
Frontiers | The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

Loop | Jessica Zucman-Rossi
Loop | Jessica Zucman-Rossi

Study Points Toward New Ways to Prevent Liver Cancer | Mirage News
Study Points Toward New Ways to Prevent Liver Cancer | Mirage News

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma  with fibrolamellar-like features and activated PKA
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA

The pro-oncogenic effect of the lncRNA H19 in the development of chronic  inflammation-mediated hepatocellular carcinoma | Request PDF
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Request PDF

Stefano Caruso - Wikipedia
Stefano Caruso - Wikipedia

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy  Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

APSselect
APSselect

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as  first-line treatment for metastatic clear-cell renal cell carcinoma  (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised,  phase 2 trial - UROONCO Kidney Cancer
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of  Hepatology.
10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of Hepatology.

Deleting in vivo β-catenin degradation domain in mouse hepatocytes drives  hepatocellular carcinoma or hepatoblastoma-like tumors | bioRxiv
Deleting in vivo β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumors | bioRxiv